These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8835874)

  • 1. Immunosuppressive and immunomodulatory treatment for myocarditis.
    Maisch B; Herzum M; Hufnagel G; Schonian U
    Curr Opin Cardiol; 1996 May; 11(3):310-24. PubMed ID: 8835874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive treatment for myocarditis and dilated cardiomyopathy.
    Maisch B; Herzum M; Hufnagel G; Bethge C; Schönian U
    Eur Heart J; 1995 Dec; 16 Suppl O():153-61. PubMed ID: 8682087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
    Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
    Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulating factors and immunosuppressive drugs in the therapy of myocarditis.
    Maisch B; Herzum M; Schönian U
    Scand J Infect Dis Suppl; 1993; 88():149-62. PubMed ID: 8516663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive therapy of myocarditis?].
    Schultheiss HP; Kühl U; Janda I; Schanwell M; Strauer BE
    Herz; 1992 Apr; 17(2):112-21. PubMed ID: 1577363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of dilated cardiomyopathies with and without inflammation].
    Hufnagel G; Pankuweit S; Maisch B
    Med Klin (Munich); 1998 Apr; 93(4):240-51. PubMed ID: 9594534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is immunosuppressive treatment an option for myocarditis?
    Jonas M; Hod H
    Isr J Med Sci; 1997 Nov; 33(11):762-6. PubMed ID: 9434818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID).
    Maisch B; Hufnagel G; Schönian U; Hengstenberg C
    Eur Heart J; 1995 Dec; 16 Suppl O():173-5. PubMed ID: 8682090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunosuppressive therapy in myocarditis and dilated cardiomyopathy--a critical analysis].
    Schultheiss HP
    Z Kardiol; 1989 Jun; 78(6):349-59. PubMed ID: 2667264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapy in myocarditis.
    Frustaci A; Chimenti C
    Circ J; 2015; 79(1):4-7. PubMed ID: 25452202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive treatment in autoreactive myocarditis--results from a controlled trial.
    Maisch B; Schönian U; Hengstenberg C; Herzum M; Hufnagel G; Bethge C; Bittinger A; Neumann K
    Postgrad Med J; 1994; 70 Suppl 1():S29-34. PubMed ID: 7971646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis.
    Pauschinger M; Phan MD; Doerner A; Kuehl U; Schwimmbeck PL; Poller W; Kandolf R; Schultheiss HP
    Circulation; 1999 Feb; 99(7):889-95. PubMed ID: 10027811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives.
    Noutsias M; Pauschinger M; Poller WC; Schultheiss HP; Kühl U
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):37-51. PubMed ID: 15038412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results.
    Hufnagel G; Pankuweit S; Richter A; Schönian U; Maisch B
    Herz; 2000 May; 25(3):279-85. PubMed ID: 10904853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications of anti-inflammatory drugs in cardiac diseases.
    Algalarrondo V; Boycott H; Eliahou L; Mabille M; Slama MS
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(1):3-13. PubMed ID: 23286286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and Fulminant Myocarditis: a Pragmatic Clinical Approach to Diagnosis and Treatment.
    Ammirati E; Veronese G; Cipriani M; Moroni F; Garascia A; Brambatti M; Adler ED; Frigerio M
    Curr Cardiol Rep; 2018 Sep; 20(11):114. PubMed ID: 30259175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocarditis in childhood: results of a decade's research].
    Schmaltz AA; Kandolf R
    Klin Padiatr; 2001; 213(1):1-7. PubMed ID: 11225467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Etiopathogenetic differentiation of inflammatory cardiomyopathy. Immunosuppression and immunomodulation].
    Kühl U; Pauschinger M; Schultheiss HP
    Internist (Berl); 1997 Jun; 38(6):590-601. PubMed ID: 9265004
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiinflammatory therapy in myocarditis.
    Vallejo J; Mann DL
    Curr Opin Cardiol; 2003 May; 18(3):189-93. PubMed ID: 12826819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders.
    Frustaci A; Chimenti C; Calabrese F; Pieroni M; Thiene G; Maseri A
    Circulation; 2003 Feb; 107(6):857-63. PubMed ID: 12591756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.